Form 4: Exact Sciences Executive Brian Baranick Reports Stock Transactions

Brian Baranick, General Manager of Precision Oncology at Exact Sciences, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.

Summary

• On February 29, 2024, Brian Baranick, General Manager of Precision Oncology at Exact Sciences, vested 4,724 shares of common stock from restricted stock units.
• Following the vesting, Mr. Baranick sold 2,323 shares on March 1, 2024, at a price of $59.32 per share to cover withholding taxes related to the vesting.
• After these transactions, Mr. Baranick directly owns 14,095 shares of Exact Sciences common stock and indirectly owns 454 shares held in a 401(k) plan.
• Mr. Baranick also holds an additional 46,318 vested and unvested options and restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the buying and selling activities of company executives. It's common for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the impact is likely minimal given the relatively small number of shares involved.

Key Dates